Ron Lloyd

President & Chief Executive Officer

Ron Lloyd is a global healthcare executive with an outstanding record of building businesses, raising capital, navigating products through development and successful launch, and consistently exceeding financial targets. He brings an uncommon combination of commercial savvy and scientific knowledge. Ron most recently served as President and CEO of Aziyo Biologics, a commercial stage regenerative medicine company. As CEO, Ron doubled sales for the branded products by executing commercial partnerships with industry leaders and took the company public.

Prior to Aziyo Biologics, Ron was President of the hospital division at Mallinckrodt Pharmaceuticals, where he accelerated sales growth and completed four business development transactions to build a late-stage product pipeline. Ron also held key leadership roles at Baxter International, serving as President of Immunology and General Manager, US BioScience, where he won the Chairman’s Award for the top-performing country with total revenue exceeding $3.2 billion. Before joining Baxter, Ron served in several senior leadership roles at Abbott Laboratories.

Ron holds a Master of Science in Industrial Administration from Carnegie Mellon University and a Bachelor of Arts in Management Science from Westminster College.

Tomorrow’s spinal surgery solutions start here.

“Innovating solutions that
improve patients’ lives.”